Cartesian Therapeutics (RNAC) Falls 0.16% – Below 200‑Day Avg., 18% Down This Month
Cartesian Therapeutics (RNAC) fell 0.16% to $6.21, remaining below its 200‑day average and down 18.6% month‑to‑date, amid broader biotech volatility.
- CARTESIAN THERAPEUTICS INC
- United States
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
2 minutes to read